Journal
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Volume 13, Issue 10, Pages 2046-2053Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138920112802273326
Keywords
Sjogren's syndrome; epigenetics; DNA methylation; microRNAs; post-translational modifications; human endogenous retrovirus
Funding
- Association Francaise du Gougerot-Sjogren et des Syndromes Secs
Ask authors/readers for more resources
There is growing evidence that epigenetics, the study of heritable changes in gene expression that do not involve mutations in the DNA itself, may play an essential role in autoimmune diseases (AID). In Sjogren's syndrome (SS), a chronic AID characterized by an epithelis of the exocrine glands, epigenetic studies have focused on three mechanisms: DNA methylation and its consequences including human endogenous retrovirus (HERV) expression; microRNA expression; and protein post-translational modifications associated with autoantibody production. Although in its infancy, comprehension of the epigenetic (dys)regulation in SS may help us to understand: why SS affects predominantly middle-aged women; why genetically predisposed individuals develop SS but not others; why flare-ups occur; why treatment responses differ between patients; and why some patients develop lymphoma. From these studies will arise a better comprehension of the pathophysiology of SS as well as development of new diagnostic and prognostic biomarkers, and novel therapeutics for prevention and perhaps early intervention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available